OPTIMISTIC: Observational Prolonged Trial in Myotonic Dystrophy Type 1 to Improve QoL-Standards, a Target Identification Collaboration (joint with Concentris Research Management GmbH,Radboud University Nijmegen-Holland, Newcastle University, Munich University, University of Paris Est Creteil, Glasgow University and Industrial Partner)

Myotonic Dystrophy Keyphrases 100%

MSH3 Keyphrases 50%

Aerobic Training Keyphrases 50%

Randomized Controlled Trial Keyphrases 50%

Usual Care Keyphrases 50%

Disease Severity Keyphrases 50%

Somatic Symptoms Keyphrases 50%

Somatic Instability Keyphrases 50%